Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey
about
Anticoagulants in cancerWhen are breast cancer patients at highest risk of venous thromboembolism? A cohort study using English health care data.Anticoagulant utilization evaluation in a teaching hospital: a prospective study.FRAGMATIC: a randomised phase III clinical trial investigating the effect of fragmin added to standard therapy in patients with lung cancerEpidemiology and pathophysiology of cancer-associated thrombosis.Brief report: graduated compression stocking thromboprophylaxis for elderly inpatients: a propensity analysis.Venous thromboembolic disease and cancerEarly changes in the haemostatic and procoagulant systems after chemotherapy for breast cancerThe challenges of managing cancer related venous thromboembolism in the palliative care settingThe management of venous thromboembolism in cancer patients.The Hemostasis Apparatus in Pancreatic Cancer and Its Importance beyond Thrombosis.Management of venous thromboembolism in the palliative care setting.Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines.Prevention of venous thromboembolism in hospitalized patients with cancer.Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer.Successful retreatment with osimertinib after osimertinib-induced acute pulmonary embolism in a patient with lung adenocarcinoma: A case report.
P2860
Q26825228-0B6BD358-CB39-474F-A0CB-C97AA1CCEA25Q31024426-1D9A6F12-256E-4648-9F27-EBE6C995F767Q33394991-3AADCEF9-0690-403D-A95F-8A95988BAD00Q33508936-7E652F62-B1FA-45EF-AE6F-44A1ED0DF660Q35860789-3062592E-79DD-440E-A43C-3EFFAED19472Q35901673-CCE8C8C9-EF7C-4EED-B6CA-9174010A7343Q36636027-003B1213-8D05-4EBB-BE8C-B9A4F9A86DB4Q36936061-F5E56E66-64EA-4E5E-A4D2-98857EB1F277Q36995852-F5C52B60-19EE-47B5-A8FF-1DC905A30B40Q37029835-23FDBCCC-6348-46CC-BD8C-50BDF5127DE4Q37129768-626BAE86-7EDE-4722-92B1-53F42C4338FBQ37133050-3E97A682-FA70-4D95-98AD-8D37D97CCD2CQ37265242-5C2A9538-AE49-4A5C-AA32-751D390BE871Q37393398-634BFBAA-6B87-442E-A80E-5EE25C023B3BQ37479698-85B6FDC5-17CB-450D-AD92-9BB245DDD4CFQ42121568-EED53CDE-C4AE-421E-A091-18B663A082F4
P2860
Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey
@ast
Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey
@en
Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey
@nl
type
label
Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey
@ast
Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey
@en
Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey
@nl
prefLabel
Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey
@ast
Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey
@en
Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey
@nl
P2093
P356
P1433
P1476
Prophylaxis for venous thromboembolism during treatment for cancer: questionnaire survey
@en
P2093
P2860
P304
P356
10.1136/BMJ.327.7415.597
P407
P577
2003-09-01T00:00:00Z